POMC Chromosome 2
Proopiomelanocortin
Upload your DNA to see your personal genotypes for variants in POMC.
What This Gene Does
This gene encodes a preproprotein that undergoes extensive, tissue-specific, post-translational processing via cleavage by subtilisin-like enzymes known as prohormone convertases. There are eight potential cleavage sites within the preproprotein and, depending on tissue type and the available convertases, processing may yield as many as ten biologically active peptides involved in diverse cellular functions. The encoded protein is synthesized mainly in corticotroph cells of the anterior pituitary where four cleavage sites are used; adrenocorticotrophin, essential for normal steroidogenesis and the maintenance of normal adrenal weight, and lipotropin beta are the major end products. In other tissues, including the hypothalamus, placenta, and epithelium, all cleavage sites may be used, giving rise to peptides with roles in pain and energy homeostasis, melanocyte stimulation, and immune modulation. These include several distinct melanotropins, lipotropins, and endorphins that are contained within the adrenocorticotrophin and beta-lipotropin peptides. The antimicrobial melanotropin alpha peptide exhibits antibacterial and antifungal activity. Mutations in this gene have been associated with early onset obesity, adrenal insufficiency, and red hair pigmentation. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jan 2016]
Gene Info
Gene Group
Neuropeptides
Locus Type
gene with protein product
Location
2p23.3
Ensembl
ENSG00000115138
Associated Conditions (8)
Obesity
Obesity due to pro-opiomelanocortin deficiency
Inherited obesity
POMC-related disorder
early-onset
susceptibility to
Early onset severe obesity
Inborn genetic diseases
Key Variants
RS139229417
Conflicting classifications of pathogenicity
Obesity, Obesity due to pro-opiomelanocortin deficiency, Obesity
Health Risk
RS141309351
Conflicting classifications of pathogenicity
Obesity due to pro-opiomelanocortin deficiency, Inherited obesity, POMC-related disorder
Health Risk
RS142715775
Conflicting classifications of pathogenicity
POMC-related disorder, POMC-related disorder
Health Risk
RS149540566
Conflicting classifications of pathogenicity
Obesity, Obesity due to pro-opiomelanocortin deficiency, POMC-related disorder
Health Risk
RS199636726
Conflicting classifications of pathogenicity
Obesity, Obesity due to pro-opiomelanocortin deficiency, Obesity
Health Risk
RS28932470
Conflicting classifications of pathogenicity
Obesity due to pro-opiomelanocortin deficiency, Obesity, POMC-related disorder
Health Risk
RS28932472
Conflicting classifications of pathogenicity
Obesity, early-onset, susceptibility to
Health Risk
RS760352559
Conflicting classifications of pathogenicity
Obesity, Obesity due to pro-opiomelanocortin deficiency, POMC-related disorder
Health Risk
RS80326661
Conflicting classifications of pathogenicity
Obesity, POMC-related disorder, Obesity
Health Risk
RS8192605
Conflicting classifications of pathogenicity
Obesity due to pro-opiomelanocortin deficiency, Obesity, Obesity due to pro-opiomelanocortin deficiency
Health Risk
RS8192606
Conflicting classifications of pathogenicity
Obesity due to pro-opiomelanocortin deficiency, Obesity, POMC-related disorder
Health Risk
RS2149220092
Likely pathogenic
Obesity, Obesity
Health Risk
All Variants (27)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS139229417 | Health Risk | Conflicting classifications of pathogenicity | Obesity, Obesity due to pro-opiomelanocortin deficiency, Obesity |
| RS141309351 | Health Risk | Conflicting classifications of pathogenicity | Obesity due to pro-opiomelanocortin deficiency, Inherited obesity, POMC-related disorder |
| RS142715775 | Health Risk | Conflicting classifications of pathogenicity | POMC-related disorder, POMC-related disorder |
| RS149540566 | Health Risk | Conflicting classifications of pathogenicity | Obesity, Obesity due to pro-opiomelanocortin deficiency, POMC-related disorder |
| RS199636726 | Health Risk | Conflicting classifications of pathogenicity | Obesity, Obesity due to pro-opiomelanocortin deficiency, Obesity |
| RS28932470 | Health Risk | Conflicting classifications of pathogenicity | Obesity due to pro-opiomelanocortin deficiency, Obesity, POMC-related disorder |
| RS28932472 | Health Risk | Conflicting classifications of pathogenicity | Obesity, early-onset, susceptibility to |
| RS760352559 | Health Risk | Conflicting classifications of pathogenicity | Obesity, Obesity due to pro-opiomelanocortin deficiency, POMC-related disorder |
| RS80326661 | Health Risk | Conflicting classifications of pathogenicity | Obesity, POMC-related disorder, Obesity |
| RS8192605 | Health Risk | Conflicting classifications of pathogenicity | Obesity due to pro-opiomelanocortin deficiency, Obesity, Obesity due to pro-opiomelanocortin deficiency |
| RS8192606 | Health Risk | Conflicting classifications of pathogenicity | Obesity due to pro-opiomelanocortin deficiency, Obesity, POMC-related disorder |
| RS2149220092 | Health Risk | Likely pathogenic | Obesity, Obesity |
| RS757720012 | Health Risk | Likely pathogenic | — |
| RS121918111 | Health Risk | Pathogenic | Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS121918112 | Health Risk | Pathogenic | Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS1470594332 | Health Risk | Pathogenic | — |
| RS1553400259 | Health Risk | Pathogenic | Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS1558628852 | Health Risk | Pathogenic | — |
| RS1573250294 | Health Risk | Pathogenic | Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS1573254045 | Health Risk | Pathogenic | Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS1671498215 | Health Risk | Pathogenic | — |
| RS2465563629 | Health Risk | Pathogenic | Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS746815510 | Health Risk | Pathogenic | Inborn genetic diseases, POMC-related disorder, Inborn genetic diseases |
| RS753856820 | Health Risk | Pathogenic | Obesity due to pro-opiomelanocortin deficiency, Obesity, Early onset severe obesity |
| RS781244602 | Health Risk | Pathogenic | POMC-related disorder, POMC-related disorder |
| RS796065034 | Health Risk | Pathogenic | Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS796065035 | Health Risk | Pathogenic | Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |